SYBR:F SSgA SPDR ETFs Europe I Public Limited Company-SPDR Barclays 3-10 Year U.S. Corporate Bond UCITS ETF

EUR 28.05 -0.24 ( -0.84%)
Icon

SSgA SPDR ETFs Europe I Public Limited Company-SPDR Barclays 3-10 Year U.S. Corporate Bond UCITS ETF (SYBR:F) Stock Analysis and Price Targets

ETF | Others | F
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 28.05

-0.24 (-0.84%)

EUR 0.23B

N/A

EUR 0.00

N/A

Icon

SYBR:F

SSgA SPDR ETFs Europe I Public Limited Company-SPDR Barclays 3-10 Year U.S. Corporate Bond UCITS ETF (EUR)
ETF | F
EUR 28.05
-0.24 ( -0.84%)

SSgA SPDR ETFs Europe I Public Limited Company-SPDR Barclays 3-10 Year U.S. Corporate Bond UCITS ETF (SYBR:F) Stock Forecast

N/A

Based on the SSgA SPDR ETFs Europe I Public Limited Company-SPDR Barclays 3-10 Year U.S. Corporate Bond UCITS ETF stock forecast from 0 analysts, the average analyst target price for SSgA SPDR ETFs Europe I Public Limited Company-SPDR Barclays 3-10 Year U.S. Corporate Bond UCITS ETF is not available over the next 12 months. SSgA SPDR ETFs Europe I Public Limited Company-SPDR Barclays 3-10 Year U.S. Corporate Bond UCITS ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of SSgA SPDR ETFs Europe I Public Limited Company-SPDR Barclays 3-10 Year U.S. Corporate Bond UCITS ETF is Bearish, which is based on 1 positive signals and 3 negative signals. At the last closing, SSgA SPDR ETFs Europe I Public Limited Company-SPDR Barclays 3-10 Year U.S. Corporate Bond UCITS ETF’s stock price was EUR 28.05. SSgA SPDR ETFs Europe I Public Limited Company-SPDR Barclays 3-10 Year U.S. Corporate Bond UCITS ETF’s stock price has changed by -1.50% over the past week, -2.81% over the past month and +4.11% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...